Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2074
Abstract: We improved a previous pharmacological target adverseāevent (TAE) profile model to predict adverse events (AEs) on US Food and Drug Administration (FDA) drug labels at the time of approval. The new model uses more drugs…
read more here.
Keywords:
event;
adverse event;
drug labels;
target adverse ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of diabetes and its complications"
DOI: 10.1016/j.jdiacomp.2017.08.005
Abstract: AIMS FDA-approved drug labels are an important source of information for clinicians who prescribe medications for treatment of diabetes. We reviewed drug labels to (1) understand the landscape of classes of medications approved for type…
read more here.
Keywords:
drug labels;
safety;
cardiovascular safety;
fda approved ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.12692
Abstract: Many drug labels contain information on pharmacogenomic biomarkers (PGBMs), but the information is not necessarily actionable. Pharmacogenomics Knowledgebase (PharmGKB) aims to clarify the level of action for PGBMs (PGx levels) implied in each label as…
read more here.
Keywords:
information;
drug labels;
pharmacogenomic biomarkers;
biomarkers interpretation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Environmental Research and Public Health"
DOI: 10.3390/ijerph19116665
Abstract: The aim of this study was to investigate the level of misunderstanding of medication information in Korean adults after stratifying by level of health literacy and to identify the factors influencing the misunderstanding of medication…
read more here.
Keywords:
information;
level;
health literacy;
drug ... See more keywords